Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0001209191-23-009237 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-14 | 2023-02-13 | VRTX | Tatsis Ourania | EVP, Chief Reg, Quality Off | S - Sale | $298.99 | -275 | 66.0K | -0.4% | -$82.2K |
| M | 2023-02-14 | 2023-02-10+ | VRTX | Tatsis Ourania | EVP, Chief Reg, Quality Off | F - Tax | $297.02 | -4,372 | 69.0K | -6% | -$1.30M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-13 | S | D | 64 | $299.88 | 65,776 | D | — | — | (F2) Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $299.88 (range $299.62 to $300.53). |
| 2 | Common | Common Stock | 2023-02-13 | S | D | 11 | $300.79 | 65,765 | D | — | — | |
| 3 | Common | Common Stock | 2023-02-13 | S | D | 120 | $298.98 | 65,840 | D | — | — | (F2) Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $298.98 (range $298.53 to $299.50). |
| 4 | Common | Common Stock | 2023-02-13 | S | D | 78 | $298.11 | 65,960 | D | — | — | (F2) Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $298.11 (range $297.51 to $298.50). |
| 5 | Common | Common Stock | 2023-02-13 | S | D | 2 | $295.84 | 66,038 | D | — | — | |
| 6 | Common | Common Stock | 2023-02-13 | F | D | 2,995 | $298.26 | 66,040 | D | — | — | |
| 7 | Common | Common Stock | 2023-02-10 | F | D | 1,377 | $294.33 | 69,035 | D | — | — |